APA (7th ed.) Citation

H, G., C, K., P, G., D, K., L, G., M, E., . . . JJ, K. (2023). Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. Leukemia, 37(10), 2129. https://doi.org/10.1038/s41375-023-02008-6

Chicago Style (17th ed.) Citation

H, Gisslinger, et al. "Event-free Survival in Patients with Polycythemia Vera Treated with Ropeginterferon Alfa-2b Versus Best Available Treatment." Leukemia 37, no. 10 (2023): 2129. https://doi.org/10.1038/s41375-023-02008-6.

MLA (9th ed.) Citation

H, Gisslinger, et al. "Event-free Survival in Patients with Polycythemia Vera Treated with Ropeginterferon Alfa-2b Versus Best Available Treatment." Leukemia, vol. 37, no. 10, 2023, p. 2129, https://doi.org/10.1038/s41375-023-02008-6.